Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 SEK | -2.22% | +0.43% | -53.17% |
04-22 | Lipidor AB Postpones the Publication of Annual Report for 2023 | CI |
03-21 | Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2 | CI |
- Stock Market
- Equities
- LIPI Stock
- News Lipidor AB
- MarketScreener Strategies